Showing results (1-10 of 178) with videos related to
Sort By:
Pageof 18
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|July 14, 2009
Principles of modular tumor therapyAlbrecht Reichle, Gerhard C HildebrandtCancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|March 25, 2009
Systems biology: a therapeutic target for tumor therapyAlbrecht Reichle, Thomas VogtBritish Journal of Haematology|April 23, 2020
Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantationGerhard C Hildebrandt, Nelson ChaoBiomedicines|May 25, 2017
Advances in the Use of Regulatory T-Cells for the Prevention and Therapy of Graft-vs.-Host DiseaseReshma Ramlal, Gerhard C HildebrandtCurrent Cancer Drug Targets|September 24, 2005
New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapyChristian Hafner, Albrecht Reichle, Thomas VogtFrontiers in Pharmacology|April 12, 2019
A Computational Model of Tumor Growth and AnakoinosisPan Pantziarka, Lina Ghibelli, Albrecht ReichleCurrent Topics in Microbiology and Immunology|April 10, 2010
The chemokine system: a possible therapeutic target in acute graft versus host diseaseNicolai A Kittan, Gerhard C HildebrandtCurrent Hematologic Malignancy Reports|February 10, 2015
A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient populationSabarinath Venniyil Radhakrishnan, Gerhard C HildebrandtFrontiers in Pharmacology|December 21, 2020
Metabolic Reprogramming-A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has BegunReena Kumari, Senthilnathan Palaniyandi, Gerhard C HildebrandtClinical Case Reports|November 12, 2021
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID-19 vaccinationSnigdha Nutalapati, Garima Gupta, Gerhard C HildebrandtPageof 18